A Clinical Study of Autologous Bone Marrow Mononuclear Cells for Cerebral Palsy Patients: A New Frontier

Table 3

Number of patients showing improvements based on the GMFCS levels of the patient six months after intervention.

GMFCS levels	Mild improvements	Moderate improvements	Major improvements
Level I	0	1	1
Level II	1	4	3
Level III	2	3	1
Level IV	1	6	2
Level V	6	6	3